Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.
| Current Price | ₹3,295.00 |
|---|---|
| Market Cap | ₹24,561 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 69.2 |
| Return on Equity | 23.52% |
| 52-Week Range | ₹1,086.40 – ₹3,444.30 |
| Beta (1Y) | 0.21 |
| Dividend Yield | 0.08% |
1. Custom Synthesis and Manufacturing of Speciality Chemicals-100%
Acutaas Chemicals Ltd is trading at ₹3,295.00, with a market capitalisation of ₹24,561 Cr.
Acutaas Chemicals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space.
Acutaas Chemicals Ltd has a P/E of 69.2 and a return on equity of 23.52%.